Document is current
Any future updates will be listed below
-
Authors
Li, Li
Li, Fengyang
Hu, Xiuhong
Wu, Zengshuai
Ren, Wenbo
Wang, Tingting
Ji, Zhengchao
Li, Na
Gu, Jingmin
Sun, Changjiang
Feng, Xin
Han, Wenyu
Huang, Jing
Lei, Liancheng
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (31772715)
- License Information
-
More Information
Article History
Received: 30 April 2022
Accepted: 29 July 2022
First Online: 8 August 2022
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki, and approved by the Human Research Ethics Committee of The First Hospital of Jilin University (Changchun, China) (protocol code AF-IRB-032–06, date of approval: November 30, 2021). All tissues and blood samples from patients with breast cancer used in this study was approved by the and complied with the Declaration of Helsinki. Written informed consent was obtained from all subjects. Informed consent was obtained from all subjects involved in the study.
: Not Applicable.
: The authors declare no conflict of interest.
